Pharmacological modulation of monocytes and macrophages

Current Opinion in Pharmacology

Volumn 17, Issue 1, 2014, Pages 38-44

  Mantovani, Alberto ^a,b   Vecchi, Annunciata ^a   Allavena, Paola ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

15 LIPOXYGENASE 2; ARACHIDONATE 15 LIPOXYGENASE; CARBOPLATIN; CISPLATIN; COLONY STIMULATING FACTOR 1; CYTOKINE; DOXORUBICIN; FLUOROURACIL; GAMMA INTERFERON; GEMCITABINE; GRANZYME A; GRANZYME B; INTERLEUKIN 34; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 2; PERFORIN; PERFORIN 1; TRABECTEDIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; IMMUNOLOGIC FACTOR;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CELL INVASION; CELL SURVIVAL; DEPLETION; HUMAN; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MONOCYTE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR ASSOCIATED NEUTROPHIL; UTERINE CERVIX CARCINOMA; ANIMAL; CELL LINEAGE; CHEMOTAXIS; DRUG DESIGN; DRUG EFFECTS; IMMUNOLOGY; NEOPLASMS; PATHOLOGY; PHENOTYPE; RADIATION RESPONSE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINEAGE; CHEMOTAXIS; DRUG DESIGN; HUMANS; IMMUNOLOGIC FACTORS; MACROPHAGE ACTIVATION; MACROPHAGES; MONOCYTES; NEOPLASMS; PHENOTYPE;

EID: 84905391073     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2014.07.004     Document Type: Review

References (83)

1. A. Sica, and A. Mantovani Macrophage plasticity and polarization: in vivo veritas J Clin Invest 122 2012 787 795
2. F.O. Martinez, L. Helming, and S. Gordon Alternative activation of macrophages: an immunologic functional perspective Annu Rev Immunol 27 2009 451 483
3. D.M. Mosser, and J.P. Edwards Exploring the full spectrum of macrophage activation Nat Rev Immunol 8 2008 958 969
4. S.K. Biswas, and A. Mantovani Orchestration of metabolism by macrophages Cell Metab 15 2012 432 437
5. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
6. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 2001 539 545 (Pubitemid 32173595)
7. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
8. A. Mantovani, B. Bottazzi, F. Colotta, S. Sozzani, and L. Ruco The origin and function of tumor-associated macrophages Immunol Today 13 1992 265 270
9. B.Z. Qian, and J.W. Pollard Macrophage diversity enhances tumor progression and metastasis Cell 141 2010 39 51
10. S.K. Biswas, and A. Mantovani Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm Nat Immunol 11 2010 889 896
11. M. De Palma, and C.E. Lewis Macrophage regulation of tumor responses to anticancer therapies Cancer Cell 23 2013 277 286
12. S. Gordon, and P.R. Taylor Monocyte and macrophage heterogeneity Nat Rev Immunol 5 2005 953 964 (Pubitemid 41746764)
13. D. Duluc, M. Corvaisier, S. Blanchard, L. Catala, P. Descamps, E. Gamelin, S. Ponsoda, Y. Delneste, M. Hebbar, and P. Jeannin Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages Int J Cancer 125 2009 367 373
14. L.M. Coussens, L. Zitvogel, and A.K. Palucka Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339 2013 286 291
15. S.M. Pyonteck, L. Akkari, A.J. Schuhmacher, R.L. Bowman, L. Sevenich, D.F. Quail, O.C. Olson, M.L. Quick, J.T. Huse, and V. Teijeiro et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression Nat Med 19 2013 1264 1272
16. F. Balkwill Cancer and the chemokine network Nat Rev Cancer 4 2004 540 550 (Pubitemid 38868623)
17. B. Bottazzi, N. Polentarutti, R. Acero, A. Balsari, D. Boraschi, P. Ghezzi, M. Salmona, and A. Mantovani Regulation of the macrophage content of neoplasms by chemoattractants Science 220 1983 210 212 (Pubitemid 13115270)
18. A. Mantovani, P. Allavena, S. Sozzani, A. Vecchi, M. Locati, and A. Sica Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors Semin Cancer Biol 14 2004 155 160 (Pubitemid 38586740)
19. J.R. Reed, M.D. Stone, T.C. Beadnell, Y. Ryu, T.J. Griffin, and K.L. Schwertfeger Fibroblast growth factor receptor 1 activation in mammary tumor cells promotes macrophage recruitment in a CX3CL1-dependent manner PLoS ONE 7 2012 e45877
20. T. Ueno, M. Toi, H. Saji, M. Muta, H. Bando, K. Kuroi, M. Koike, H. Inadera, and K. Matsushima Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer Clin Cancer Res 6 2000 3282 3289 (Pubitemid 30637758)
21. P. Allavena, and A. Mantovani Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment Clin Exp Immunol 167 2012 195 205
22. B. Bierie, and H.L. Moses Transforming growth factor beta (TGF-beta) and inflammation in cancer Cytokine Growth Factor Rev 21 2010 49 59
23. M. Gironella, C. Calvo, A. Fernandez, D. Closa, J.L. Iovanna, J. Rosello-Catafau, and Folch-PuyF E. Reg3beta deficiency impairs pancreatic tumor growth by skewing macrophage polarization Cancer Res 73 2013 5682 5694
24. G. Jin, H.I. Kawsar, S.A. Hirsch, C. Zeng, X. Jia, Z. Feng, S.K. Ghosh, Q.Y. Zheng, A. Zhou, and T.M. McIntyre et al. An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis PLoS ONE 5 2010 e10993
25. E.Y. Lin, V. Gouon-Evans, A.V. Nguyen, and J.W. Pollard The macrophage growth factor CSF-1 in mammary gland development and tumor progression J Mammary Gland Biol Neoplasia 7 2002 147 162 (Pubitemid 38420772)
26. N. Linde, W. Lederle, S. Depner, N. van Rooijen, C.M. Gutschalk, and M.M. Mueller Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages J Pathol 227 2012 17 28
27. J. Zhang, S. Sud, K. Mizutani, M.R. Gyetko, and K.J. Pienta Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model Neoplasia 13 2011 23 30
28. E.C. Keeley, B. Mehrad, and R.M. Strieter CXC chemokines in cancer angiogenesis and metastases Adv Cancer Res 106 2010 91 111
29. A. Mantovani, M.A. Cassatella, C. Costantini, and S. Jaillon Neutrophils in the activation and regulation of innate and adaptive immunity Nat Rev Immunol 11 2011 519 531
30. G. Lazennec, and A. Richmond Chemokines and chemokine receptors: new insights into cancer-related inflammation Trends Mol Med 16 2010 133 144
31. +Gr1 high F4/80- cells and promotes tumor progression PLoS ONE 7 2012 e44080
32. T. Jamieson, M. Clarke, C.W. Steele, M.S. Samuel, J. Neumann, A. Jung, D. Huels, M.F. Olson, S. Das, and R.J. Nibbs et al. Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis J Clin Invest 122 2012 3127 3144
33. S.I. Grivennikov, K. Wang, D. Mucida, C.A. Stewart, B. Schnabl, D. Jauch, K. Taniguchi, G.Y. Yu, C.H. Osterreicher, and K.E. Hung et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth Nature 491 2012 254 258
34. V. Cortez-Retamozo, M. Etzrodt, A. Newton, P.J. Rauch, A. Chudnovskiy, C. Berger, R.J. Ryan, Y. Iwamoto, B. Marinelli, and R. Gorbatov et al. Origins of tumor-associated macrophages and neutrophils Proc Natl Acad Sci U S A 109 2012 2491 2496
35. V. Cortez-Retamozo, M. Etzrodt, A. Newton, R. Ryan, F. Pucci, S.W. Sio, W. Kuswanto, P.J. Rauch, A. Chudnovskiy, and Y. Iwamoto et al. Angiotensin II drives the production of tumor-promoting macrophages Immunity 38 2013 296 308
36. D.M. Kuang, Q. Zhao, Y. Wu, C. Peng, J. Wang, Z. Xu, X.Y. Yin, and L. Zheng Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma J Hepatol 54 2011 948 955
37. S.L. Zhou, Z. Dai, Z.J. Zhou, X.Y. Wang, G.H. Yang, Z. Wang, X.W. Huang, J. Fan, and J. Zhou Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma Hepatology 56 2012 2242 2254
38. C.A. Dumitru, H. Gholaman, S. Trellakis, K. Bruderek, N. Dominas, X. Gu, A. Bankfalvi, T.L. Whiteside, S. Lang, and S. Brandau Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation Int J Cancer 129 2011 859 869
39. S. Trellakis, K. Bruderek, C.A. Dumitru, H. Gholaman, X. Gu, A. Bankfalvi, A. Scherag, J. Hutte, N. Dominas, and G.F. Lehnerdt et al. Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease Int J Cancer 129 2011 2183 2193
40. L.Y. Fang, K. Izumi, K.P. Lai, L. Liang, L. Li, H. Miyamoto, W.J. Lin, and C. Chang Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling Cancer Res 73 2013 5633 5646
41. J. Zhang, L. Patel, and K.J. Pienta CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis Cytokine Growth Factor Rev 21 2010 41 48
42. B.Z. Qian, J. Li, H. Zhang, T. Kitamura, J. Zhang, L.R. Campion, E.A. Kaiser, L.A. Snyder, and J.W. Pollard CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis Nature 475 2011 222 225
43. S. Rozel, C.J. Galban, K. Nicolay, K.C. Lee, S. Sud, C. Neeley, L.A. Snyder, T.L. Chenevert, A. Rehemtulla, and B.D. Ross et al. Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model J Cell Biochem 107 2009 58 64
44. K. Garber First results for agents targeting cancer-related inflammation J Natl Cancer Inst 101 2009 1110 1112
45. C.L. Manthey, D.L. Johnson, C.R. Illig, R.W. Tuman, Z. Zhou, J.F. Baker, M.A. Chaikin, R.R. Donatelli, C.F. Franks, and L. Zeng et al. JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia Mol Cancer Ther 8 2009 3151 3161
46. S. Aharinejad, P. Paulus, M. Sioud, M. Hofmann, K. Zins, R. Schafer, E.R. Stanley, and D. Abraham Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice Cancer Res 64 2004 5378 5384 (Pubitemid 39006559)
47. P. Paulus, E.R. Stanley, R. Schafer, D. Abraham, and S. Aharinejad Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts Cancer Res 66 2006 4349 4356
48. S. Goswami, E. Sahai, J.B. Wyckoff, M. Cammer, D. Cox, F.J. Pixley, E.R. Stanley, J.E. Segall, and J.S. Condeelis Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop Cancer Res 65 2005 5278 5283 (Pubitemid 40827339)
49. D.G. DeNardo, D.J. Brennan, E. Rexhepaj, B. Ruffell, S.L. Shiao, S.F. Madden, W.M. Gallagher, N. Wadhwani, S.D. Keil, and S.A. Junaid et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy Cancer Discov 1 2011 54 67
50. I. Daurkin, E. Eruslanov, T. Stoffs, G.Q. Perrin, C. Algood, S.M. Gilbert, C.J. Rosser, L.M. Su, J. Vieweg, and S. Kusmartsev Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway Cancer Res 71 2011 6400 6409
51. E.J. Villablanca, L. Raccosta, D. Zhou, R. Fontana, D. Maggioni, A. Negro, F. Sanvito, M. Ponzoni, B. Valentinis, and M. Bregni et al. Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses Nat Med 16 2010 98 105
52. L. Raccosta, R. Fontana, D. Maggioni, C. Lanterna, E.J. Villablanca, A. Paniccia, A. Musumeci, E. Chiricozzi, M.L. Trincavelli, and S. Daniele et al. The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils J Exp Med 210 2013 1711 1728
53. H.K. Jensen, F. Donskov, N. Marcussen, M. Nordsmark, F. Lundbeck, and H. von der Maase Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma J Clin Oncol 27 2009 4709 4717
54. G.L. Beatty, E.G. Chiorean, M.P. Fishman, B. Saboury, U.R. Teitelbaum, W. Sun, R.D. Huhn, W. Song, D. Li, and L.L. Sharp et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans Science 331 2011 1612 1616
55. T. Hagemann, T. Lawrence, I. McNeish, K.A. Charles, H. Kulbe, R.G. Thompson, S.C. Robinson, and F.R. Balkwill "Re-educating" tumor-associated macrophages by targeting NF-kappaB J Exp Med 205 2008 1261 1268 (Pubitemid 351831483)
56. P. Allavena, M. Grandi, M. D'Incalci, O. Geri, F.C. Giuliani, and A. Mantovani Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin-2 activated killer cells and by activated monocytes Int J Cancer 40 1987 104 107 (Pubitemid 17099978)
57. N. Colombo, F. Peccatori, C. Paganin, S. Bini, M. Brandely, C. Mangioni, A. Mantovani, and P. Allavena Anti-tumor immunomodulatory activity of intraperitoneal IFN-gamma in ovarian carcinoma patients with minimal residual tumor after chemotherapy Int J Cancer 51 1992 42 46
58. A. Mantovani, N. Polentarutti, W. Luini, G. Peri, and F. Spreafico Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice J Natl Cancer Inst 63 1979 61 66 (Pubitemid 9206190)
59. A. Mantovani The interaction of cancer chemotherapy agents with mononuclear phagocytes Adv Pharmacol Chemother 19 1982 35 66 (Pubitemid 13193433)
60. A. Mantovani, and A. Vecchi Interaction of cancer chemotherapy agents with the mononuclear phagocyte system Prog Drug Res 35 1990 487 519
61. E.M. Dijkgraaf, M. Heusinkveld, B. Tummers, L.T. Vogelpoel, R. Goedemans, V. Jha, J.W. Nortier, M.J. Welters, J.R. Kroep, and S.H. van der Burg Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment Cancer Res 73 2013 2480 2492
62. F. Lotti, A.M. Jarrar, R.K. Pai, M. Hitomi, J. Lathia, A. Mace, G.A. Gantt Jr., K. Sukhdeo, J. DeVecchio, and A. Vasanji et al. Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A J Exp Med 210 2013 2851 2872
63. L. Zitvogel, L. Galluzzi, M.J. Smyth, and G. Kroemer Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance Immunity 39 2013 74 88
64. G. Kroemer, L. Galluzzi, O. Kepp, and L. Zitvogel Immunogenic cell death in cancer therapy Annu Rev Immunol 31 2013 51 72
65. D. Alizadeh, M. Trad, N.T. Hanke, C.B. Larmonier, N. Janikashvili, B. Bonnotte, E. Katsanis, and N. Larmonier Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer Cancer Res 74 2014 104 118
66. Y. Ma, L. Galluzzi, L. Zitvogel, and G. Kroemer Autophagy and cellular immune responses Immunity 39 2013 211 227
67. N. Figueiredo, A. Chora, H. Raquel, N. Pejanovic, P. Pereira, B. Hartleben, A. Neves-Costa, C. Moita, D. Pedroso, and A. Pinto et al. Anthracyclines induce DNA damage response-mediated protection against severe sepsis Immunity 39 2013 874 884
68. M. Bruchard, G. Mignot, V. Derangere, F. Chalmin, A. Chevriaux, F. Vegran, W. Boireau, B. Simon, B. Ryffel, and J.L. Connat et al. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth Nat Med 19 2013 57 64
69. J.B. Mitchem, D.J. Brennan, B.L. Knolhoff, B.A. Belt, Y. Zhu, D.E. Sanford, L. Belaygorod, D. Carpenter, L. Collins, and D. Piwnica-Worms et al. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses Cancer Res 73 2013 1128 1141
70. D.T. Le, and E.M. Jaffee Harnessing immune responses in the tumor microenvironment: all signals needed Clin Cancer Res 19 2013 6061 6063
71. S.C. Formenti, and S. Demaria Systemic effects of local radiotherapy Lancet Oncol 10 2009 718 726
72. S.C. Formenti, and S. Demaria Radiation therapy to convert the tumor into an in situ vaccine Int J Radiat Oncol Biol Phys 84 2012 879 880
73. J.S. Russell, and J.M. Brown The irradiated tumor microenvironment: role of tumor-associated macrophages in vascular recovery Front Physiol 4 2013 157
74. C.S. Tsai, F.H. Chen, C.C. Wang, H.L. Huang, S.M. Jung, C.J. Wu, C.C. Lee, W.H. McBride, C.S. Chiang, and J.H. Hong Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth Int J Radiat Oncol Biol Phys 68 2007 499 507 (Pubitemid 46694184)
75. M. De Palma, G. Coukos, and D. Hanahan A new twist on radiation oncology: low-dose irradiation elicits immunostimulatory macrophages that unlock barriers to tumor immunotherapy Cancer Cell 24 2013 559 561
76. S.V. Kozin, W.S. Kamoun, Y. Huang, M.R. Dawson, R.K. Jain, and D.G. Duda Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation Cancer Res 70 2010 5679 5685
77. J. Xu, J. Escamilla, S. Mok, J. David, S. Priceman, B. West, G. Bollag, W. McBride, and L. Wu CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer Cancer Res 73 2013 2782 2794
78. A. Kalbasi, C.H. June, N. Haas, and N. Vapiwala Radiation immunotherapy: a synergistic combination J Clin Invest 123 2013 2756 2763
79. F. Klug, H. Prakash, P.E. Huber, T. Seibel, N. Bender, N. Halama, C. Pfirschke, R.H. Voss, C. Timke, and L. Umansky et al. Low-dose irradiation programs macrophage differentiation to an iNOS(+)/M1 phenotype that orchestrates effective T cell immunotherapy Cancer Cell 24 2013 589 602
80. G. Germano, R. Frapolli, C. Belgiovine, A. Anselmo, S. Pesce, M. Liguori, E. Erba, S. Uboldi, M. Zucchetti, and F. Pasqualini et al. Role of macrophage targeting in the anti-tumor activity of Trabectedin Cancer Cell 23 2013 249 262
81. C. Sessa, F. De Braud, A. Perotti, J. Bauer, G. Curigliano, C. Noberasco, F. Zanaboni, L. Gianni, S. Marsoni, and J. Jimeno et al. Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes fails J Clin Oncol 23 2005 1867 1874 (Pubitemid 46211364)
82. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol 23 2002 549 555 (Pubitemid 35223554)
83. D.R. Getts, R.L. Terry, M.T. Getts, C. Deffrasnes, M. Muller, C. van Vreden, T.M. Ashhurst, B. Chami, D. McCarthy, and H. Wu et al. Therapeutic inflammatory monocyte modulation using immune-modifying microparticles Sci Transl Med 6 2014 219ra7